Skip to main content

Table 1 Characteristics of the study population in Erfurt, Germany, winter 2000/2001

From: Ultrafine particles and platelet activation in patients with coronary heart disease – results from a prospective panel study

   Mean (SD)
Age [years]   66 (6.0)
BMI* [kg/m 2 ]   28 (3.4)
   No. (%)
History of   
  Coronary heart disease 57 (100)
  Angina pectoris 40 (68)
  Myocardial infarction 43 (75)
  Bypass surgery/balloon dilatation 49 (86)
  Stroke 3 (5)
  Diabetes mellitus 13 (23)
  Hypertension 40 (70)
  Chronic bronchitis 2 (4)
  COPD 5 (9)
  Hay fever 2 (4)
  Chronic kidney disease 6 (11)
Smoking   
  Never smoker 15 (26)
  Ex-smoker 42 (74)
Medication use Anti-hyperlipidemic medication 29 (51)
  Platelet aggregation inhibitors  
     Acetylsalicylic acid 52 (91)
     Thienopyridines 3 (5)
  1. * BMI, Body mass index
  2. † COPD, Chronic obstructive pulmonary disease
  3. ‡ SD, standard deviation